Faruk TOKTAŞ, ŞENOL YAVUZ, Kadir Kaan ÖZSİN, Umut Serhat SANRI, TAMER TÜRK, MEHMET TUĞRUL GÖNCÜ

Cardiac myxomas: an analysis of 39 patients

Objectives. Myxomas are the most common benign primary heart tumors. They have serious complications including intracardiac blood flow obstruction and embolic events. The aim of the study was to assess our experiences related to patients undergoing surgical resection for cardiac myxomas. Methods. The medical records of 39 patients, aged 16 to 76 years (mean, 47.5 years), who were operated on for primary cardiac myxomas between January 1994 and December 2016 at our clinic were retrospectively evaluated. Demographic, clinical, operative and postoperative data were obtained from these hospital medical records. Cardiac myxomas were diagnosed by transthoracic echocardiography. Preoperative coronary angiography was performed in patients over 40 years of age and those with symptoms of coronary disease. In routine follow-up after discharge the patients were checked by echocardiography. Long-term cumulative survival was analyzed using the Kaplan-Meier method. Results. There was no in-hospital mortality. The majority (61.5%) of patients were female. The most common encountered localization of myxoma was the left atrium (76.9%), and the classic posterior approach from interatrial groove was preferred in 32 (82.1%) patients. Mean follow-up was 6.05 ± 3.75 years (range, 1-10 years). Five (12.8%) patients were lost on long-term follow-up. Kaplan-Meier curves, cumulative proportion surviving of patients at 1-, 2-, 5-, and 10-year were 97.4%, 91.7%, 84.7%, and 84.7%, respectively. No hospital mortality was observed in any of the patients. There was no recurrence in our series. Conclusions. Myxoma is the disease that can lead to complications such as embolic events and intracardiac blood flow obstruction. It can be excised with a low rate of morbidity and mortality. Surgical resection should be performed promptly after diagnosis in order to prevent potential complications.

Keywords:

Cardiac tumors, myxomas, cardiac surgery, echocardiography,

PDF

___

[1] Roberts W. Cardiac neoplasms. In: Topol E, ed. Textbook of Cardiovascular Medicine. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:917-22.
[2] Yavuz S, Toktas F, Eris C, Ata Y, Turk T, Goncu T. Left atrial mass in a patient with previous coronary artery bypass grafting. Journal-CVS 2014;2:7-9.
[3] Hill M, Cherry C, Maloney M, Midyette P. Surgical resection of atrial myxomas. AORN J 2010;92:393-406.
[4] Yavuz S, Toktas F, Eris C, Ata Y, Turk T, Goncu T. Recurrent multiple cardiac myxomas. Brastisl Lek Listy 2010;111:549-51.
[5] Aggarwal SK, Barik R, Sarma TCSR, Iyer VR, Sai V, Mishra J, et al. Clinical presentation and investigation findings in cardiac myxomas: new insight from the developing world. Am Heart J 2007;154:1102-7.
[6] Meşe B, Arıkan A, Karabörk O, Özsin KK. [Using the superior septal approach to excise a giant left atrial myxoma: A case report]. Turk Gogus Kalp Dama 2012;20:596-9. [Article in Turkish]
[7] Kaplan M, Demirtas MM, Cimen S, Gercekoglu H, Yapici F, Ozler A. [Cardiac myxomas: surgical experience with 45 cases]. Turk Gogus Kalp Dama 2002;10:11-4. [Article in Turkish]
[8] Taş S, Tunçer E, Boyacıoğlu K, Antal Dönmez A, Bengi Bakal R, Kayalar N, et al. Cardiac myxomas: a 27-year surgical experience. Turk Gogus Kalp Dama 2014;22:526-33.
[9] Swartz MF, Lutz CJ, Chandan VS, Landas S, Fink GW. Atrial myxomas: pathologic types, tumor location, and presenting symptoms. J Card Surg 2006;21:435-40.
[10] Garatti A, Nano G, Canziani A, Gagliardotto P, Mossuto E, Frigiola A, et al. Surgical excision of cardiac myxomas: twenty years experience at a single institution. Ann Thorac Surg 2012;93:825-31.
[11] Ha JW, Kang WC, Chung N, Chang BC, Rim SJ, Kwon JW, et al. Echocardiographic and morphologic characteristics of left atrial myxoma and their relation to systemic embolism. Am J Cardiol 1999;83:1579-82.
[12] Kimura K, Iezumi Y, Noma S, Fukuda K. Left to right protrusion of a left atrial myxoma through a patent foramen ovale in a patient with ‘cryptogenic’ pulmonary embolism. Eur Heart J 2010;31:1247.
[13] He DK, Zhang YF, Liang Y, Ye SX, Wang C, Kang B, et al. Risk factors for embolism in cardiac myxoma: a retrospective analysis. Med Sci Monit 2015;21:1146-54.
[14] Garatti A, Nano G, Canziani A, Gagliardotto P, Mossuto E, Frigiola A, et al. Surgical excision of cardiac myxomas: twenty years experience at a single institution. Ann Thorac Surg 2012;93:825-31.
[15] Shahbaaz MK, Sanki PK, Hossain MZ, Charles A, Bhattacharya S, Sarkar UN. Cardiac myxoma: a surgical experience of 38 patients over 9 years, at SSKM hospital Kolkata, India. South Asian J Cancer 2013;2:83-6.
[16] McCarthy PM, Schaff HV, Winkler HZ, Lieber MM, Carney JA. Deoxyribonucleic acid ploidy pattern of cardiac myxomas. Another predictor of biologically unusual myxomas. J Thorac Cardiovasc Surg 1989;98:1083-6.
[17] Yavuz S, Celkan A, Ata Y, Mavi M, Turk T, Eris C, et al. Mitral valve myxoma. Asian Cardiovasc Thorac Ann 2000;8:64-6.
[18] Gucu A, Demir D, Kahraman N, Engin M, Ozyazicioglu AF, Goncu MT. Mitral valve myxoma associated with intracranial tumor: a case report. Eur Res J 2016;2:233-5.
[19] Erdil N, Ates S, Cetin L, Demirkilic U, Sener E, Tatar H. Frequency of left atrial myxoma with concomitant coronary artery disease. Surg Today 2003;33:328-31.
[20] Ito S, Endo A, Okada T, Nakamura T, Adachi T, Nakashima R, et al. Acute myocardial infarction due to left atrial myxoma. Intern Med 2016;55:49-54.